Inhalation Sciences Sweden AB (publ) releases Interim Report Q3, January 1- September 30, 2020
(Stockholm, Sweden, November 26, 2020) During the third quarter 2020, Inhalation Sciences repositioned its CRO business under a new brand name – ‘Inhalation Research Services’, or IRS, offering precise, predictive early-stage research data. ISAB installed its first DissolvIt® module in the laboratory of an international company in Switzerland. ISAB has initiated the recruitment process for a Director of Sales to strengthen its commercial organization, as well as a Regulatory and Quality manager to strengthen the team and support the planned clinical trial of PreciseInhale. The company's Board